Skip to main content
. 2000 Oct 23;2000(4):CD002849. doi: 10.1002/14651858.CD002849

Comparison 3. Meprobamate versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Reduction of >85% at 12 month f/up 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
1.1 Prescription only 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Prescription and individual counselling 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Prescription and group counselling 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]